Hofseth BioCare ASA - Laporan Laba Rugi (TTM)

Hofseth BioCare ASA
GB ˙ LSE ˙ NO0010598683
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Hofseth BioCare ASA menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 57 69 68 79 85 88 102 96 113 120 134 185 205 219 226 230 248 266 274 262
Change (%) 20.77 -2.44 16.20 7.74 3.58 15.92 -5.13 17.19 6.67 11.61 37.64 10.63 6.75 3.47 1.76 7.82 7.04 3.20 -4.37
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 52 40 42 51 60 77 91 87 98 102 122 131 139 165 151 172 188 190 200 188
Change (%) -24.29 5.43 21.86 18.61 27.90 17.78 -4.21 12.50 4.81 18.75 7.68 6.40 18.33 -8.46 13.60 9.41 1.11 5.33 -5.94
% of Revenue 91.06 57.08 61.69 64.69 71.22 87.94 89.35 90.22 86.60 85.09 90.54 70.83 68.12 75.51 66.80 74.57 75.67 71.48 72.96 71.76
Gross Operating Profit 5 30 26 28 24 11 11 9 15 18 13 54 65 54 75 59 60 76 74 74
Change (%) 479.90 -12.90 7.09 -12.17 -56.60 2.38 -12.84 60.49 18.69 -29.16 324.25 20.90 -18.00 40.27 -22.06 3.16 25.47 -2.14 -0.13
% of Revenue 8.94 42.92 38.31 35.31 28.78 12.06 10.65 9.78 13.40 14.91 9.46 29.17 31.88 24.49 33.20 25.43 24.33 28.52 27.04 28.24
SG&A 46 43 45 47 44 60 63 64 66 76 76 77 78 76 79 80 84 91 94 97
Change (%) -6.36 4.47 4.68 -6.15 37.92 5.10 0.41 4.19 14.57 -0.51 2.14 1.14 -2.41 3.85 1.56 4.73 8.47 3.16 2.40
% of Revenue 79.41 61.57 65.93 59.39 51.73 68.88 62.46 66.10 58.77 63.12 56.27 41.76 38.17 34.90 35.03 34.96 33.96 34.41 34.39 36.83
R&D
Change (%)
% of Revenue
OpEx 152 161 169 185 198 206 229 227 240 249 266 281 293 321 318 342 366 371 379 374
Change (%) 6.24 4.56 9.43 7.26 4.17 10.86 -0.52 5.68 3.57 6.82 5.81 4.17 9.57 -0.83 7.51 6.83 1.35 2.36 -1.49
% of Revenue 264.73 232.88 249.58 235.04 233.98 235.32 225.04 235.97 212.80 206.63 197.76 152.02 143.14 146.92 140.81 148.77 147.40 139.57 138.44 142.60
Operating Income -94 -92 -101 -106 -113 -119 -127 -131 -127 -128 -131 -96 -88 -103 -92 -112 -118 -105 -105 -112
Change (%) -2.58 9.83 4.90 6.90 4.62 7.11 3.16 -2.78 0.83 2.33 -26.76 -8.26 16.10 -10.00 21.61 4.79 -10.65 0.25 5.99
% of Revenue -164.73 -132.88 -149.58 -135.04 -133.98 -135.32 -125.04 -135.97 -112.80 -106.63 -97.76 -52.02 -43.14 -46.92 -40.81 -48.77 -47.40 -39.57 -38.44 -42.60
Interest Expense -9 -9 -9 -9 -7 -9 -10 -11 -11 -10 -10 -10 -10 -8 -9 -10 -11 -16 -17 -19
Change (%) 6.85 -3.71 0.27 -19.15 30.60 2.93 9.07 8.56 -13.06 2.06 -2.98 1.01 -24.24 13.01 12.41 19.86 36.57 5.32 14.07
% of Revenue -15.04 -13.31 -13.13 -11.33 -8.50 -10.72 -9.52 -10.95 -10.14 -8.26 -7.56 -5.33 -4.86 -3.45 -3.77 -4.16 -4.63 -5.91 -6.03 -7.19
Net Income -104 -102 -111 -115 -120 -126 -135 -139 -136 -137 -140 -105 -93 -107 -98 -121 -133 -125 -129 -137
Change (%) -2.27 8.78 3.93 4.27 5.09 6.98 2.77 -1.92 0.76 1.58 -24.47 -11.76 14.70 -8.28 23.84 10.15 -6.13 3.28 5.89
% of Revenue -182.16 -147.42 -164.36 -147.00 -142.27 -144.34 -133.20 -144.29 -120.75 -114.06 -103.81 -56.97 -45.44 -48.82 -43.28 -52.67 -53.80 -47.19 -47.22 -52.28

Source: Capital IQ

Other Listings
NO:HBC
US:HOFBF
GB:HBCO
DE:HBQ € 0.13
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista